Capstone Investment Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,089	Closed	-$727K	–	892
2024 Q3	$727K	Buy	+13,089	New	+$727K	﹤0.01%	351
2024 Q2	–	Sell	-4,863	Closed	-$227K	–	1363
2024 Q1	$227K	Buy	+4,863	New	+$227K	﹤0.01%	1136